Viewing StudyNCT00434031



Ignite Creation Date: 2024-05-05 @ 5:20 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00434031
Status: WITHDRAWN
Last Update Posted: 2012-07-30
First Post: 2007-02-09

Brief Title: CETRA Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast Cancer
Sponsor: National Cancer Institute Naples
Organization: National Cancer Institute Naples

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
primary View
locally advanced View
stage II View
stage IIIa View
stage IIIb View
HER-2 positive View